HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use DUAVEE safely and effectively. See full prescribing information for DUAVEE.
DUAVEE® (conjugated estrogens/bazedoxifene) tablets for oral use
Initial U.S. approval: 2013
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, AND PROBABLE DEMENTIA
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.